Haemonetics target price raised to $144 from $125
HAE•Raymond James raised its target price for Haemonetics to $144 from $125.
Related News
Quanome agrees to acquire 5% stake in QAI Labs in $5 million all-stock deal
QNME•
Tectonic Therapeutic participates in Stifel and Piper Sandler healthcare conferences
TECX•
AMD expands Google Cloud collaboration to power confidential AI on TPU 8tx
AMD•
Corvus plans $2.00-per-share offer for CDT Equity
CDT•
CoreWeave announces multi-year agreement with Wayve
CRWV•